IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $503 | +11.5% | 11,096 | +1.0% | 0.04% | +5.6% |
| Q2 2023 | $451 | +11.1% | 10,988 | -3.4% | 0.04% | +20.0% |
| Q1 2023 | $406 | -4.7% | 11,372 | +0.9% | 0.03% | -14.3% |
| Q4 2022 | $426 | -99.9% | 11,272 | +10.8% | 0.04% | -16.7% |
| Q3 2022 | $450,000 | -3.4% | 10,170 | -19.3% | 0.04% | 0.0% |
| Q2 2022 | $466,000 | +50.8% | 12,597 | +51.2% | 0.04% | +320.0% |
| Q1 2022 | $309,000 | – | 8,334 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |